1. Home
  2. EVO vs FMBH Comparison

EVO vs FMBH Comparison

Compare EVO & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • FMBH
  • Stock Information
  • Founded
  • EVO 1993
  • FMBH 1865
  • Country
  • EVO Germany
  • FMBH United States
  • Employees
  • EVO N/A
  • FMBH N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • FMBH Major Banks
  • Sector
  • EVO Health Care
  • FMBH Finance
  • Exchange
  • EVO Nasdaq
  • FMBH Nasdaq
  • Market Cap
  • EVO 1.1B
  • FMBH 920.6M
  • IPO Year
  • EVO 2021
  • FMBH N/A
  • Fundamental
  • Price
  • EVO $5.44
  • FMBH $41.99
  • Analyst Decision
  • EVO Buy
  • FMBH Buy
  • Analyst Count
  • EVO 2
  • FMBH 5
  • Target Price
  • EVO $5.90
  • FMBH $43.40
  • AVG Volume (30 Days)
  • EVO 362.8K
  • FMBH 63.7K
  • Earning Date
  • EVO 11-06-2024
  • FMBH 10-31-2024
  • Dividend Yield
  • EVO N/A
  • FMBH 2.29%
  • EPS Growth
  • EVO N/A
  • FMBH N/A
  • EPS
  • EVO N/A
  • FMBH 3.24
  • Revenue
  • EVO $866,665,179.00
  • FMBH $316,387,000.00
  • Revenue This Year
  • EVO $4.56
  • FMBH N/A
  • Revenue Next Year
  • EVO $13.44
  • FMBH $4.32
  • P/E Ratio
  • EVO N/A
  • FMBH $12.94
  • Revenue Growth
  • EVO N/A
  • FMBH 22.37
  • 52 Week Low
  • EVO $2.85
  • FMBH $28.86
  • 52 Week High
  • EVO $12.00
  • FMBH $43.52
  • Technical
  • Relative Strength Index (RSI)
  • EVO 69.82
  • FMBH 58.60
  • Support Level
  • EVO $4.34
  • FMBH $41.29
  • Resistance Level
  • EVO $4.95
  • FMBH $43.52
  • Average True Range (ATR)
  • EVO 0.21
  • FMBH 1.30
  • MACD
  • EVO 0.12
  • FMBH 0.27
  • Stochastic Oscillator
  • EVO 89.72
  • FMBH 77.86

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. It also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

Share on Social Networks: